Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe COVID-19”

116 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 116 results

Testing effectiveness (Phase 2)UnknownNCT04780685
What this trial is testing

A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19

Who this might be right for
Covid19
Stemedica Cell Technologies, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT04402060
What this trial is testing

APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Who this might be right for
COVIDCovid-19Coronavirus+6 more
Apellis Pharmaceuticals, Inc. 72
Large-scale testing (Phase 3)Ended earlyNCT05639192
What this trial is testing

Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease

Who this might be right for
COVID-19
Apogenix GmbH 34
Testing effectiveness (Phase 2)UnknownNCT04920760
What this trial is testing

Vitamin A Supplementation in Children With Moderate to Severe COVID-19

Who this might be right for
Covid19
Shiraz University of Medical Sciences 60
Not applicableAvailableNCT04657406
What this trial is testing

Expanded Access to Zofin for Patients With COVID-19

Who this might be right for
Covid19Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)+1 more
ZEO ScientifiX, Inc.
Testing effectiveness (Phase 2)WithdrawnNCT05018975
What this trial is testing

Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCytokine Release Syndrome
Loma Linda University
Not applicableUnknownNCT04522037
What this trial is testing

Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients

Who this might be right for
Patients Hospitalized in the Hospices Civils of LyonCOVID-19 DiseaseModerate to Severe Dyspnea+1 more
Hospices Civils de Lyon 200
Large-scale testing (Phase 3)WithdrawnNCT05157243
What this trial is testing

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Who this might be right for
COVID-19
Romark Laboratories L.C.
Large-scale testing (Phase 3)Study completedNCT06585319
What this trial is testing

Pirfenidone LP or Collagen-polyvinylpyrrolidone in COVID-19

Who this might be right for
COVID 19
Materno-Perinatal Hospital of the State of Mexico 36
Testing effectiveness (Phase 2)Study completedNCT04679415
What this trial is testing

Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia

Who this might be right for
COVID-19
ImmuneMed, Inc. 63
Testing effectiveness (Phase 2)UnknownNCT05947812
What this trial is testing

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

Who this might be right for
COVID 19 DiseaseMild to Moderate COVID 19 DiseaseSARS-CoV-2+2 more
60P Australia Pty Ltd 148
Post-approval studies (Phase 4)UnknownNCT04350671
What this trial is testing

Interferon Beta 1a in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Large-scale testing (Phase 3)UnknownNCT05445934
What this trial is testing

Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)

Who this might be right for
COVID-19
Frontier Biotechnologies Inc. 1,188
Testing effectiveness (Phase 2)Study completedNCT04625738
What this trial is testing

Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome

Who this might be right for
COVID19 ARDS
Central Hospital, Nancy, France 30
Large-scale testing (Phase 3)UnknownNCT04826822
What this trial is testing

Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19

Who this might be right for
Coronavirus InfectionPneumonia, Viral
Chita State Regional Clinical Hospital Number 1 440
Post-approval studies (Phase 4)UnknownNCT04350684
What this trial is testing

Umifenovir in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Testing effectiveness (Phase 2)Ended earlyNCT04498377
What this trial is testing

Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19

Who this might be right for
Covid19
EVIVE Biotechnology 1
Testing effectiveness (Phase 2)UnknownNCT04595136
What this trial is testing

Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient

Who this might be right for
SARS-CoV-2 Infection
United Medical Specialties 60
Testing effectiveness (Phase 2)Study completedNCT04419025
What this trial is testing

Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease

Who this might be right for
COVIDSars-CoV2SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere+1 more
Cambridge Health Alliance 165
Testing effectiveness (Phase 2)Study completedNCT04551898
What this trial is testing

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
BeiGene 181
Next Page